株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心臓インプラント装置の世界市場分析:装置別 (ペースメーカー、ICD、CRT、冠動脈ステント、心臓弁、TAVI弁)、症状別 (心筋虚血、不整脈、急性心筋梗塞)

Cardiac Implant Devices Market: By Devices (CRT, ICD, ICP, Coronary Stents [DES, BMS, Bio-Absorbable], Heart Valves, TAVI); By Geography - 2019-2024

発行 IndustryARC 商品コード 351084
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.65円で換算しております。
Back to Top
心臓インプラント装置の世界市場分析:装置別 (ペースメーカー、ICD、CRT、冠動脈ステント、心臓弁、TAVI弁)、症状別 (心筋虚血、不整脈、急性心筋梗塞) Cardiac Implant Devices Market: By Devices (CRT, ICD, ICP, Coronary Stents [DES, BMS, Bio-Absorbable], Heart Valves, TAVI); By Geography - 2019-2024
出版日: 2018年12月06日 ページ情報: 英文
概要

当レポートでは、世界の心臓インプラント装置市場の現状と今後の市場成長見通し、装置別、症状別動向、地域別分析とともに、市場に参入する主要企業のプロファイルをまとめています。

第1章 市場概要

第2章 エグゼクティブサマリー

第3章 市況

  • 市場シェア分析
  • 競合分析
    • 製品ベンチマーキング
    • 特許分析
    • エンドユーザープロファイリング
    • 上位5社財務分析

第4章 市場の力

  • 市場促進因子
  • 市場抑制力
  • 市場の課題
  • 同業界の魅力

第5章 戦略的分析

  • バリューチェーン分析
  • 機会分析
  • 製品ライフサイクル
  • 価格分析

第6章 装置別

  • 心臓再同期療法装置
  • 埋め込み除細動器
  • 埋め込み心臓ペースメーカー
  • 冠動脈ステント
  • 心臓弁置換/修復装置
  • TAVR

第7章 症状別

  • 心筋虚血
  • 急性心筋梗塞
  • 不整脈
  • その他

第8章 処置別

  • 心臓再同期療法
  • 低侵襲性心臓手術
  • 開腹心臓手術
  • 血管形成
  • 心臓弁修復または置換
  • その他

第9章 地域別分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第10章 市場エントロピー

  • 新製品上市
  • 合併・買収、連携、合弁、提携

第11章 企業プロファイル

第12章 付録

目次

Cardiac implant devices is valued $30,539million in the year 2017 and is expected to grow at a CAGR of 12.5% from 2018-2023.Cardiac implant devices is segmented based on the type of devices in which coronary stunts is having the highest market share in the year 2017 which is valued $9,542 million in the year 2017 and is anticipated to grow at a CAGR of 11.6% from 2018-2023, followed by ICDs which is valued $7,327 million in the year 2017 and is expected to grow at a CAGR of 13.0% from 2018-2023.Increase in the number of elderly people with increased chronic disease will drive the market for cardiac implant devices.What is Cardiac Implant Devices Market?

Cardiac implant devices are used to treat long term heart conditions such as heart failure and other heart dysfunctions.Implanting devices into the patient's body is the second stage of the cardiac treatment.Oral medication is considered first and then the devices are implanted into the patient's body.This cardiac implant devices are segmented based on the device types in which ICDs are considered as the most commonly used device.Advancements in ICD devices are improving the cardiac treatments.

Market Research and Market Trends of Cardiac Implant Device Market

Cardio vascular device research laboratory is actively involved in the research and development of new medical devices.Their main focus of area include heart failure medical devices and wireless medical devices monitoring system.

MoMe Kardia device is a wearable device used for monitoring the patient condition and the recorded information is continuously stream to cloud.This device gives an alert message if there is any disturbance in the patient condition which helps to address them quickly.

Centers for Medicare and Medicaid service (CMS) has proposed changes in ICD device with advanced technology.The advancement in technology in ICD device is a battery powered device placed under the skin of the patient that keeps a track of the person's heart rate.Thin wires connect the ICD to heart.If there is any abnormal heart rhythm detected the device will deliver an electronic shock to restore a normal heart beat.This device can prevent a patient from sudden deaths.

ICD has transformed to use an advanced technology by using Medtronic care link monitor device which is a small convenient device that allows patients to gather information by holding an antenna over the implanted cardiac device.This data is automatically downloaded by the monitor and sent through an internet connection.Clinicians can access the patient's data by logging onto a website from anywhere.

Implantable drug delivery system is a device which is implanted inside the patient's body which deliver small amount of drugs on a regular basis.By this system the patient does not need to be injected.By using implantable drug delivery system it gives more consistent drug level in blood when compared to using injections which makes the treatment more effective which will also reduce side effects.The dosage of the drug can be adjusted according to the patient requirements.

Cardiac system which is a small pacemaker implanted into a patient body which continuously monitor the heartbeat and as soon as AF (Atrial fibrillation) is detected it emits low energy electrical pulse that are hardly felt by the patient.This system does not require any separate set of delivery devices and the system can be switched off and on repetitively as per the patient's convenience.

Who are the Major Players in Food diagnostic equipment and consumable market?

The companies referred in the market research report includes Ametek Inc, Beckman coulter Inc, Biomerieux Inc, Bio-rad laboratories, Bruker Corporation and many more.

What is our report scope?

The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market.Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2018-2024.All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy - M's, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1. Cardiac Implant Devices Market Overview

2. Executive Summary

3. Cardiac Implant Devices - Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
    • 3.2.1. Product Benchmarking
    • 3.2.2. Patent Analysis
    • 3.2.3. End user profiling
    • 3.2.4. Top 5 Financials Analysis

4. Cardiac Implant Devices - Market Forces

  • 4.1. Market Drivers
  • 4.2. Market Constraints
  • 4.3. Market Challenges
  • 4.4. Attractiveness of the Industry
    • 4.4.1. Power of Suppliers
    • 4.4.2. Power of Customers
    • 4.4.3. Threat of New entrants
    • 4.4.4. Threat of Substitution
    • 4.4.5. Degree of Competition

5. Cardiac Implant Devices Market - Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Opportunities Analysis
  • 5.3. Product lifecycle
  • 5.4. Pricing Analysis

6. Cardiac Implant Devices Market- By Devices

  • 6.1. Cardiac Resynchronization Therapy Devices (CRT'S)
  • 6.2. Implantable Cardioverter Defibrillators (ICD'S)
  • 6.3. Implantable Cardiac Pacemakers (ICPs)
  • 6.4. Coronary Stents
  • 6.5. Heart Valve Replacement/Repair Devices
  • 6.6. TAVR (Transcatheter Aortic Valve Replacement) Valves

7. Cardiac Implant Devices Market- By Disease Conditions

  • 7.1. Myocardial Ischemia
  • 7.2. Acute Myocardial Infarction
  • 7.3. Arrhythmias
  • 7.4. Others

8. Cardiac Implant Devices Market Classification- By Procedure

  • 8.1. Cardiac Resynchronization Therapy (CRT)
  • 8.2. Minimally Invasive Heart Surgery
  • 8.3. Open heart surgery
  • 8.4. Angioplasty
  • 8.5. Heart Valve Repair or Replacement
  • 8.6. Others

9. Cardiac Implant Devices Market -Geographic Analysis

  • 9.1. North America
    • 9.1.1. USA
    • 9.1.2. Canada
    • 9.1.3. Mexico
    • 9.1.4. Others
  • 9.2. Europe
    • 9.2.1. France
    • 9.2.2. Germany
    • 9.2.3. Italy
    • 9.2.4. Spain
    • 9.2.5. U.K
    • 9.2.6. Others
  • 9.3. APAC
    • 9.3.1. China
    • 9.3.2. India
    • 9.3.3. Japan
    • 9.3.4. Australia
    • 9.3.5. Others
  • 9.4. ROW
    • 9.4.1. South Africa
    • 9.4.2. Russia
    • 9.4.3. Middle East
    • 9.4.4. Others

10. Market Entropy

  • 10.1. New Product Launches
  • 10.2. M&As, Collaborations, JVs and Partnerships

11. Company profiles

  • 11.1. Abbott Vascular Inc.
  • 11.2. Medtronic, Inc.
  • 11.3. Biotronik, Inc.
  • 11.4. Bentley InnoMed GmbH
  • 11.5. Elestim-Cardio
  • 11.6. Cardioelectronica GmbH
  • 11.7. Qualimed Innovative Medizinprodukte Gmbh
  • 11.8. Medico S.p.A
  • 11.9. Lepu Medical Technology
  • 11.10. Boston Scientific Corporation
  • 11.11. St. Jude Medical, Inc.
  • 11.12. Edwards Lifesciences Corporation
  • 11.13. Biosensors International Group, Ltd.
  • 11.14. Japan Lifeline Co., Ltd.
  • 11.15. Sorin S.p.A.
  • 11.16. JenaValve Technology Inc.
  • 11.17. Opto Circuits Limited
  • 11.18. Hexacath
  • 11.19. MicroPort Scientific Corporation.
  • 11.20. Cardionovum GmbH
  • 11.21. Alvimedica
  • 11.22. Amaranth Medical
  • 11.23. Stentys SA

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

12. Appendix

  • 12.1. Abbreviations
  • 12.2. Sources
  • 12.3. Research Methodology
  • 12.4. Bibliography
  • 12.5. Compilation of Expert Insights
  • 12.6. Disclaimer
Back to Top